scholarly journals Peripartum Cardiomyopathy Associated With Left Ventricular Noncompaction Phenotype and Reversible Rigid Body Rotation

Author(s):  
Ferande Peters ◽  
Bijoy K. Khandheria ◽  
Claudia dos Santos ◽  
Samantha Govender ◽  
Francois Botha ◽  
...  
Author(s):  
Attila Nemes ◽  
Kálmán Havasi ◽  
Péter Domsik ◽  
Anita Kalapos ◽  
Tamás Forster

2014 ◽  
Vol 25 (4) ◽  
pp. 768-772 ◽  
Author(s):  
Attila Nemes ◽  
Kálmán Havasi ◽  
Tamás Forster

AbstractLeft ventricular twist results from the movement of two orthogonally oriented muscular bands of the helical myocardial structure, with a consequent clockwise rotation of the left ventricular base and counterclockwise rotation of the left ventricular apex. To the best of the authors’ knowledge, this is the first time that left ventricular “rigid body rotation”, the near absence of left ventricular twist in hypoplastic right-heart syndrome, has been demonstrated.


2017 ◽  
Vol 7 (3) ◽  
pp. 378-379
Author(s):  
Attila Nemes ◽  
Árpád Kormányos ◽  
Péter Domsik ◽  
Anita Kalapos ◽  
Csaba Lengyel ◽  
...  

2018 ◽  
Vol 24 (1) ◽  
pp. 31-36 ◽  
Author(s):  
Kazuhiko Kido ◽  
Maya Guglin

In 2 distinct entities, left ventricular noncompaction (LVNC) and peripartum cardiomyopathy (PPCM), routine anticoagulation therapy is often used in current practices. However, our systematic review showed that LVNC itself was not associated with the increase in thromboembolism event rates and therapeutic anticoagulation therapy should not be considered only for LVNC, unless there is risk factor for thromboembolism. Current literature justifies prophylactic therapeutic anticoagulation in LVNC with low left ventricular ejection fraction (EF < 40%) and/or atrial fibrillation. Although not specifically studied, the presence of intracardiac thrombi by echocardiography or other imaging studies should also prompt anticoagulation therapy. There is limited evidence available for the use of anticoagulation in patients with PPCM, but our systematic review showed that anticoagulation should be recommended only for patients with PPCM especially with an EF < 35% until EF is recovered, as well as for patients with PPCM treated with bromocriptine.


Sign in / Sign up

Export Citation Format

Share Document